What is the National Prostate Cancer Audit?
NPCA is the first national clinical audit of the care that men receive following a diagnosis of prostate cancer. It is designed to collect information about the diagnosis, management and treatment of every patient newly diagnosed with prostate cancer in England and Wales, and their outcomes. The findings from the audit will contribute to changes in clinical practice ensuring that patients receive the best care possible and experience an improved quality of life.
The audit was commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit Programme. The Royal College of Surgeons’ Clinical Effectiveness Unit (CEU) was awarded the contract for the audit, which started on the 1st April 2013, and is managed as a partnership between a team of clinical, cancer information and audit experts from the British Association of Urological Surgeons, the British Uro-oncology Group, the National Cancer Registration Service and CEU.
‘A national clinical audit of prostate cancer care will improve clinical practice and patient outcomes, and ultimately save lives. The success of this audit has our full support and commitment’
Adrian Joyce, President of BAUS (until June 2014)
‘BUG supports NPCA as it is a fantastic opportunity to provide accurate data directly from MDTs with minimal administrative burden on staff and patients alike. This will improve the quality of care and outcome of patients nationwide.’
Simon Russell, Secretary of BUG